Skip to main content


Volume 4 Supplement 2

Current perspectives on the treatment of rheumatic diseases with infliximab


Edited by Peter E Lipsky and Ravinder N Maini

Supported by an educational grant from Centocor, Inc.

  1. Content type: Supplement

    Since the initial characterization of tumor necrosis factor alpha (TNFα), it has become clear that TNFα has diverse biologic activity. The realization that TNFα plays a role in rheumatoid arthritis (RA) has le...

    Authors: Ravinder N Maini and Marc Feldmann

    Citation: Arthritis Research & Therapy 2002 4(Suppl 2):S22

    Published on:

Annual Journal Metrics